Low Dose Epcoritamab Plus GemOx in R/R DLBCL

NCT07451652 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Relapsed/Refractory Diffuse Large B Cell Lymphoma

Interventions

DRUG: Epcoritamab
DRUG: Gemcitabine (1000 mg/m2)
DRUG: Oxaliplatin

Sponsor

Hospital Universitario Dr. Jose E. Gonzalez